Alldigi Tech provides outsourced business process management and human resources technology services, specifically handling customer support, payroll processing, and employee record management for global corporate clients.
The company possesses a narrow moat driven by high switching costs in its payroll and HCM technology segment, where it manages over 19 million employee records. This is corroborated by a durable ROCE of 24.4% and high revenue retention rates, though the BPM segment remains more commoditized and competitive.
Management has demonstrated disciplined capital allocation by divesting the non-core labor law compliance business to focus on high-margin digital services while maintaining a consistent dividend payout policy and funding capacity expansions in Manila and India from internal accruals.
The investment collapsed as the commoditized BPM segment's margin compression accelerated, dragging down the higher-quality payroll business. The CEO transition in 2026 proved poorly managed, leading to a loss of strategic focus and an inability to navigate the rising lease liabilities and labor costs. Meanwhile, the parent company, Digitide, utilized related party transactions to siphon value, and the anticipated growth in Manila failed to offset the rationalization of domestic contracts, leaving the company with stranded capacity and a shrinking bottom line.
RichFakir rates Alldigi Tech Ltd's business quality as decent — 69/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Alldigi Tech Ltd is trading about 33% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Alldigi Tech Ltd is: Buy candidate. A decent business trading below what we think it is worth — so it makes our buy list.
RichFakir's educational estimate of Alldigi Tech Ltd's fair value is about ₹1,244 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →